# OMEROS CORPORATION (OMER) FY2026 Q2 Balance Sheet

- Company: OMEROS CORPORATION (OMER)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-12, accession number 0001437749-26-027318
- Page: https://plicit.ai/financials/omer/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/omer-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 286,833,000 US dollars
- **Current assets**: 185,240,000 US dollars
- **Non-current assets**: 101,593,000 US dollars
- **Liabilities (calculated)**: 338,182,000 US dollars
- **Current liabilities**: 94,963,000 US dollars
- **Non-current liabilities**: 243,219,000 US dollars
- **Equity**: negative 51,349,000 US dollars
- **Short-term investments**: 129,965,000 US dollars
- **OMIDRIA contract royalty asset**: 25,603,000 US dollars
- **Receivables**: 21,301,000 US dollars
- **Prepaid expense and other assets**: 5,541,000 US dollars
- **Cash and cash equivalents**: 1,988,000 US dollars
- **Inventory**: 842,000 US dollars
- **OMIDRIA contract royalty asset, non-current**: 90,875,000 US dollars
- **Right of use assets**: 8,284,000 US dollars
- **Property and equipment, net**: 1,380,000 US dollars
- **Restricted investments**: 1,054,000 US dollars
- **2029 Notes repurchase obligation, net**: 31,259,000 US dollars
- **Accrued expenses**: 29,269,000 US dollars
- **OMIDRIA royalty obligation**: 21,511,000 US dollars
- **Lease liabilities**: 6,583,000 US dollars
- **Accounts payable**: 6,341,000 US dollars
- **2026 Notes, net**: 0 US dollars
- **OMIDRIA royalty obligation, non-current**: 136,370,000 US dollars
- **2029 Notes embedded derivative, non-current**: 55,216,000 US dollars
- **2029 Notes, non-current, net**: 42,032,000 US dollars
- **Other accrued liabilities, non-current**: 5,702,000 US dollars
- **Lease liabilities, non-current**: 3,899,000 US dollars
- **Additional paid-in capital**: 792,333,000 US dollars
- **Common stock, par value $0.01 per share, 150,000,000 shares authorized at June 30, 2026 and December 31, 2025; 72,087,984 and 71,670,791 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively.**: 721,000 US dollars
- **Preferred stock, par value $0.01 per share, 20,000,000 shares authorized; none issued and outstanding at June 30, 2026 and December 31, 2025.**: 0 US dollars
- **Accumulated deficit**: negative 844,403,000 US dollars

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.